Design and rationale of the non-interventional, edoxaban treatment in routiNe clinical prActice in patients with venous ThromboEmbolism in Europe (ETNA-VTE-Europe) study

BACKGROUND: Venous thromboembolism (VTE, including deep vein thrombosis [DVT] and pulmonary embolism [PE]) has an annual incidence rate of 104–183 per 100,000 person-years. After a VTE episode, the two-year recurrence rate is about 17%. Consequently, effective and safe anticoagulation is paramount....

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Thromb J
Glavni autori: Cohen, Alexander T., Ay, Cihan, Hainaut, Philippe, Décousus, Hervé, Hoffmann, Ulrich, Gaine, Sean, Coppens, Michiel, da Silva, Pedro Marques, Castro, David Jimenez, Amann-Vesti, Beatrice, Brüggenjürgen, Bernd, Levy, Pierre, Bastida, Julio Lopez, Vicaut, Eric, Laeis, Petra, Fronk, Eva-Maria, Zierhut, Wolfgang, Malzer, Thomas, Bramlage, Peter, Agnelli, Giancarlo
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2018
Teme:
Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5928573/
https://ncbi.nlm.nih.gov/pubmed/29719492
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12959-018-0163-7
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items